Micropapillary bladder carcinoma

A clinicopathological study of 20 cases

Sonny Lennart Johansson, G. Borghede, S. Holmäng

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

Purpose: Micropapillary bladder carcinoma is rare, with only 18 cases reported to date. We report 20 additional cases with long-term followup. Materials and Methods: A total of 680 patients with an initial diagnosis of bladder carcinoma in western Sweden in 1987 and 1989 were prospectively registered. The clinical records of all 816 patients with bladder cancer treated at Sahlgrenska University Hospital with external beam irradiation between 1962 and 1989 were reviewed. The histopathological material was reviewed and immunohistochemical analyses were performed on 20 cases identified with micropapillary bladder carcinoma. Results: The incidence of micropapillary bladder carcinoma was 0.7%. Mean patient age at diagnosis was 69 years (range 45 to 82) and the male-to-female ratio was 2.3:1. All but 5 patients had stage T3a disease or higher. There was no difference in stage or prognosis between the 5 prospectively identified patients and those treated with external beam irradiation. Only 2 patients had micropapillary bladder carcinoma as the only pattern, while 1 had 10% and the remainder had 20 to 95% micropapillary bladder carcinoma. Transitional cell carcinoma was noted in 17 patients and 5 had areas of gland forming adenocarcinoma. Carcinoma in situ was noted in 13 patients and 15 had lymphatic invasion. Only 5 patients survived 5 years, 1 of whom died of bladder cancer after 7 years. Radiation and chemotherapy did not seem to be effective. Conclusions: The light microscopic appearance, which is strikingly similar to ovarian papillary serous carcinoma, and immunohistochemical staining pattern lend some support to the theory that micropapillary bladder carcinoma is a variant of adenocarcinoma. Since even the focal presence of micropapillary bladder carcinoma is associated with a poor prognosis, recognition of this entity is important. Due to its rarity, the optimal treatment of micropapillary bladder carcinoma needs to be determined in a multicenter study.

Original languageEnglish (US)
Pages (from-to)1798-1802
Number of pages5
JournalJournal of Urology
Volume161
Issue number6
DOIs
StatePublished - Jan 1 1999

Fingerprint

Urinary Bladder
Carcinoma
Urinary Bladder Neoplasms
Adenocarcinoma
Transitional Cell Carcinoma
Papillary Carcinoma
Carcinoma in Situ
Sweden
Multicenter Studies
Radiation
Staining and Labeling
Light
Drug Therapy
Incidence

Keywords

  • Bladder
  • Bladder neoplasms
  • Immunohistochemistry

ASJC Scopus subject areas

  • Urology

Cite this

Micropapillary bladder carcinoma : A clinicopathological study of 20 cases. / Johansson, Sonny Lennart; Borghede, G.; Holmäng, S.

In: Journal of Urology, Vol. 161, No. 6, 01.01.1999, p. 1798-1802.

Research output: Contribution to journalArticle

Johansson, Sonny Lennart ; Borghede, G. ; Holmäng, S. / Micropapillary bladder carcinoma : A clinicopathological study of 20 cases. In: Journal of Urology. 1999 ; Vol. 161, No. 6. pp. 1798-1802.
@article{e5beaf4cde2c4d9aafe91d64d83ae073,
title = "Micropapillary bladder carcinoma: A clinicopathological study of 20 cases",
abstract = "Purpose: Micropapillary bladder carcinoma is rare, with only 18 cases reported to date. We report 20 additional cases with long-term followup. Materials and Methods: A total of 680 patients with an initial diagnosis of bladder carcinoma in western Sweden in 1987 and 1989 were prospectively registered. The clinical records of all 816 patients with bladder cancer treated at Sahlgrenska University Hospital with external beam irradiation between 1962 and 1989 were reviewed. The histopathological material was reviewed and immunohistochemical analyses were performed on 20 cases identified with micropapillary bladder carcinoma. Results: The incidence of micropapillary bladder carcinoma was 0.7{\%}. Mean patient age at diagnosis was 69 years (range 45 to 82) and the male-to-female ratio was 2.3:1. All but 5 patients had stage T3a disease or higher. There was no difference in stage or prognosis between the 5 prospectively identified patients and those treated with external beam irradiation. Only 2 patients had micropapillary bladder carcinoma as the only pattern, while 1 had 10{\%} and the remainder had 20 to 95{\%} micropapillary bladder carcinoma. Transitional cell carcinoma was noted in 17 patients and 5 had areas of gland forming adenocarcinoma. Carcinoma in situ was noted in 13 patients and 15 had lymphatic invasion. Only 5 patients survived 5 years, 1 of whom died of bladder cancer after 7 years. Radiation and chemotherapy did not seem to be effective. Conclusions: The light microscopic appearance, which is strikingly similar to ovarian papillary serous carcinoma, and immunohistochemical staining pattern lend some support to the theory that micropapillary bladder carcinoma is a variant of adenocarcinoma. Since even the focal presence of micropapillary bladder carcinoma is associated with a poor prognosis, recognition of this entity is important. Due to its rarity, the optimal treatment of micropapillary bladder carcinoma needs to be determined in a multicenter study.",
keywords = "Bladder, Bladder neoplasms, Immunohistochemistry",
author = "Johansson, {Sonny Lennart} and G. Borghede and S. Holm{\"a}ng",
year = "1999",
month = "1",
day = "1",
doi = "10.1016/S0022-5347(05)68807-6",
language = "English (US)",
volume = "161",
pages = "1798--1802",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Micropapillary bladder carcinoma

T2 - A clinicopathological study of 20 cases

AU - Johansson, Sonny Lennart

AU - Borghede, G.

AU - Holmäng, S.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Purpose: Micropapillary bladder carcinoma is rare, with only 18 cases reported to date. We report 20 additional cases with long-term followup. Materials and Methods: A total of 680 patients with an initial diagnosis of bladder carcinoma in western Sweden in 1987 and 1989 were prospectively registered. The clinical records of all 816 patients with bladder cancer treated at Sahlgrenska University Hospital with external beam irradiation between 1962 and 1989 were reviewed. The histopathological material was reviewed and immunohistochemical analyses were performed on 20 cases identified with micropapillary bladder carcinoma. Results: The incidence of micropapillary bladder carcinoma was 0.7%. Mean patient age at diagnosis was 69 years (range 45 to 82) and the male-to-female ratio was 2.3:1. All but 5 patients had stage T3a disease or higher. There was no difference in stage or prognosis between the 5 prospectively identified patients and those treated with external beam irradiation. Only 2 patients had micropapillary bladder carcinoma as the only pattern, while 1 had 10% and the remainder had 20 to 95% micropapillary bladder carcinoma. Transitional cell carcinoma was noted in 17 patients and 5 had areas of gland forming adenocarcinoma. Carcinoma in situ was noted in 13 patients and 15 had lymphatic invasion. Only 5 patients survived 5 years, 1 of whom died of bladder cancer after 7 years. Radiation and chemotherapy did not seem to be effective. Conclusions: The light microscopic appearance, which is strikingly similar to ovarian papillary serous carcinoma, and immunohistochemical staining pattern lend some support to the theory that micropapillary bladder carcinoma is a variant of adenocarcinoma. Since even the focal presence of micropapillary bladder carcinoma is associated with a poor prognosis, recognition of this entity is important. Due to its rarity, the optimal treatment of micropapillary bladder carcinoma needs to be determined in a multicenter study.

AB - Purpose: Micropapillary bladder carcinoma is rare, with only 18 cases reported to date. We report 20 additional cases with long-term followup. Materials and Methods: A total of 680 patients with an initial diagnosis of bladder carcinoma in western Sweden in 1987 and 1989 were prospectively registered. The clinical records of all 816 patients with bladder cancer treated at Sahlgrenska University Hospital with external beam irradiation between 1962 and 1989 were reviewed. The histopathological material was reviewed and immunohistochemical analyses were performed on 20 cases identified with micropapillary bladder carcinoma. Results: The incidence of micropapillary bladder carcinoma was 0.7%. Mean patient age at diagnosis was 69 years (range 45 to 82) and the male-to-female ratio was 2.3:1. All but 5 patients had stage T3a disease or higher. There was no difference in stage or prognosis between the 5 prospectively identified patients and those treated with external beam irradiation. Only 2 patients had micropapillary bladder carcinoma as the only pattern, while 1 had 10% and the remainder had 20 to 95% micropapillary bladder carcinoma. Transitional cell carcinoma was noted in 17 patients and 5 had areas of gland forming adenocarcinoma. Carcinoma in situ was noted in 13 patients and 15 had lymphatic invasion. Only 5 patients survived 5 years, 1 of whom died of bladder cancer after 7 years. Radiation and chemotherapy did not seem to be effective. Conclusions: The light microscopic appearance, which is strikingly similar to ovarian papillary serous carcinoma, and immunohistochemical staining pattern lend some support to the theory that micropapillary bladder carcinoma is a variant of adenocarcinoma. Since even the focal presence of micropapillary bladder carcinoma is associated with a poor prognosis, recognition of this entity is important. Due to its rarity, the optimal treatment of micropapillary bladder carcinoma needs to be determined in a multicenter study.

KW - Bladder

KW - Bladder neoplasms

KW - Immunohistochemistry

UR - http://www.scopus.com/inward/record.url?scp=0032845605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032845605&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(05)68807-6

DO - 10.1016/S0022-5347(05)68807-6

M3 - Article

VL - 161

SP - 1798

EP - 1802

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -